Regional Veterinary Practices Are Quietly Selling to Mars Networks

The Quiet Consolidation of an Entire Industry

Mars, Incorporated – the candy and pet food company – has been running a parallel business for decades that most people outside the veterinary world barely notice. Through its Banfield, VCA, and BluePearl hospital networks, Mars operates the largest veterinary care organization on earth. And over the past several years, it has been steadily absorbing independent regional practices, one clinic at a time, in deals that rarely make headlines but are steadily reshaping who controls animal healthcare in America.

The pattern is consistent: a multi-doctor practice in a mid-sized metro area, often founded in the 1980s or 1990s, reaches a generational inflection point. The founding veterinarian wants to retire, there is no obvious internal successor, and the economics of running a standalone clinic have grown complicated enough that selling starts to look like the rational choice. Mars or one of its network affiliates shows up with a number. Most of the time, the answer is yes.

Why Independent Practices Are Selling Now

Veterinary medicine has changed enormously in cost and complexity over the past two decades. Advanced diagnostics, specialty referral networks, 24-hour emergency care, and sophisticated pharmacy management have all raised the baseline for what a competitive practice needs to offer. A solo or small-group clinic that was thriving in 2005 by offering solid general care now faces pressure from corporate-backed competitors offering broader services, longer hours, and deeper staffing benches. The capital required to keep pace is substantial, and most independent owners are not in a position to raise it without selling equity to someone.

The workforce situation adds another layer of pressure. Veterinary school enrollment has not kept up with demand, and new graduates increasingly carry six-figure student debt loads that make the economics of buying into a private practice difficult. Corporate networks can offer structured salaries, benefits packages, clear advancement tracks, and relief from administrative overhead that private ownership demands. For many young veterinarians, joining a corporate clinic is simply the easier path – which means independent practices are competing for the same shrinking pool of talent without the same resources to attract it.

How Mars Built a Network No One Saw Coming

Mars acquired Banfield, which operates clinics inside PetSmart locations, in 2007. That deal gave the company an immediate national footprint and a subscription-based wellness plan model that generated predictable recurring revenue. The VCA acquisition in 2017 cost roughly 9.1 billion dollars and added more than 800 hospitals across the United States and Canada, turning Mars into a genuinely dominant force in the space almost overnight. BluePearl, a specialty and emergency hospital network, was already a VCA subsidiary, which meant Mars got all of it in the same transaction.

What followed the VCA deal was a quieter but relentless expansion strategy: identify high-performing regional practices, particularly those with strong community reputations and loyal client bases, and bring them into the network through acquisition rather than greenfield development. Building a new veterinary hospital from scratch is slow and expensive. Buying one that is already profitable, already staffed, and already trusted by local pet owners is faster and carries lower risk. Mars has the capital to pursue that strategy at scale in ways that no independent operator can match.

The terms of individual acquisitions are rarely disclosed. Practice owners sign non-disclosure agreements as a routine part of the deal, which means the consolidation happens largely in the dark. A clinic might rebrand over six months or retain its original name entirely – Mars often keeps local branding intact to preserve the community trust that made the practice worth buying in the first place. Clients frequently do not know their neighborhood vet clinic is now owned by the same company that makes M&Ms.

This consolidation in veterinary medicine follows patterns visible in other healthcare sectors. Regional orthopedic surgery groups have faced similar rollup pressure from private equity, with independent practices finding it increasingly difficult to compete without institutional backing. The veterinary sector differs mainly in that the consolidating buyer is a single strategic corporation rather than a rotating cast of financial sponsors – which creates a different kind of concentration risk.

What Changes After the Sale

Selling veterinarians typically receive a lump sum for the practice and are then retained as employees, often for a contractually required period of two to five years. During that window, many report that day-to-day clinical operations remain largely unchanged. The staff stays the same, appointment scheduling works the same way, and the practice continues treating the same patient population. The changes tend to arrive gradually: standardized software systems, centralized purchasing that replaces local vendor relationships, and performance metrics tracked at the network level rather than the clinic level.

The more significant changes often surface in pricing and staffing decisions. Network-owned clinics typically implement standardized fee schedules set at the corporate level, which may or may not reflect what the local market was bearing before the acquisition. Staffing ratios and scheduling decisions increasingly flow through centralized management rather than the practice owner. The founding veterinarian who once made all of those calls unilaterally becomes one voice among many inside a larger organizational structure.

Where This Is Heading

Mars is not the only buyer in this space – private equity-backed platforms like National Veterinary Associates and Pathway Vet Alliance have also been aggressively acquiring regional practices – but Mars is by far the most established and the most financially patient. It does not face the pressure of a fund lifecycle forcing an exit in five to seven years. It can hold assets indefinitely and optimize them over long time horizons, which gives it a structural advantage over financial sponsors who eventually need to sell.

The independent veterinary practice is not disappearing entirely. Rural areas, specialized niches, and markets where corporate networks have not yet penetrated still support solo and small-group ownership. Veterinarians with strong local reputations and manageable debt loads can still build viable independent businesses. But the share of practices operating outside of any corporate umbrella has been declining for years, and nothing in the current economic environment suggests that trend will reverse.

The deeper question is what this concentration means for pricing and access over the long run. When the dominant providers in a local veterinary market are all owned by the same parent company, competitive pressure on fees weakens. Pet ownership rates are high, demand for care is relatively inelastic when an animal is sick, and switching costs are real – most pet owners have a strong preference for continuity of care. That combination gives network operators considerable pricing power, and Mars now holds more of it than any single entity in the history of organized veterinary medicine.